Floatz logo

475 assets in Plasma Cell Myeloma

Therapeutic assets addressing Plasma Cell Myeloma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Thiotepa
Plasma Cell Myeloma
First Affiliated Hospital Xi'an Jiaotong UniversityP4B (62)
Aspirin
Plasma Cell Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3B (61)
Cilta-Cel
Plasma Cell Myeloma
Janssen Research & Development, LLCP4B (61)
Endoxan
Plasma Cell Myeloma
Celyad Oncology SAP3B (61)
Fludeoxyglucose
Plasma Cell Myeloma
National Cancer Institute (NCI)P3B (61)
Mesna
Plasma Cell Myeloma
Indapta Therapeutics, INC.P4B (61)
Motixafortide
Plasma Cell Myeloma
Guangzhou Gloria Biosciences Co., Ltd.P4B (61)
Palifermin
Plasma Cell Myeloma
City of Hope Medical CenterP4B (61)
Sulfamethoxazole
Plasma Cell Myeloma
Monash UniversityP3B (61)
Trimethoprim
Plasma Cell Myeloma
Monash UniversityP3B (61)
Apixaban
Plasma Cell Myeloma
Centre Hospitalier Universitaire de Saint EtienneP4B (60)
Conjugated Pneumococcal Vaccine
Plasma Cell Myeloma
Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyP4B (60)
Epirubicin
Plasma Cell Myeloma
Andrew Hantel, MDP3B (60)
hbi0101 cart
Plasma Cell Myeloma
Hadassah Medical OrganizationP2B (60)
Ibrutinib
Plasma Cell Myeloma
Anne Louise Tølbøll SørensenP4B (60)
Irinotecan
Plasma Cell Myeloma
Leaf Vertical Inc.P2B (60)
Melphalan Hydrochloride For
Plasma Cell Myeloma
Peking University People's HospitalP4B (60)
Mitoxantrone
Plasma Cell Myeloma
Affiliated Hospital of Nantong UniversityP4B (60)
Ondansetron
Plasma Cell Myeloma
Fate TherapeuticsP3B (60)
Pelareorep
Plasma Cell Myeloma
University of Southern CaliforniaP1/2B (60)
Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]-
Plasma Cell Myeloma
The Affiliated People's Hospital of Ningbo UniversityP3B (60)
Plerixafor
Plasma Cell Myeloma
Thomas Jefferson UniversityP3B (60)
Recombinant Human Hyaluronidase
Plasma Cell Myeloma
National Cancer Institute (NCI)P2B (60)
Rituximab
Plasma Cell Myeloma
Indapta Therapeutics, INC.P2B (60)
Sapanisertib
Plasma Cell Myeloma
National Cancer Institute (NCI)P2B (60)
Selinexor
Plasma Cell Myeloma
Natalie CallanderP3B (60)
Tocilizumab
Plasma Cell Myeloma
SCRI Development Innovations, LLCP4B (60)
Venetoclax
Plasma Cell Myeloma
OncotherapeuticsP3B (60)
Xembify
Plasma Cell Myeloma
Grifols Therapeutics LLCP3B (60)
Nivolumab
Plasma Cell Myeloma
Wake Forest University Health SciencesP3B (59)
Sirolimus
Plasma Cell Myeloma
National Cancer Institute (NCI)P3B (59)
Arlocabtagene Autoleucel
Plasma Cell Myeloma
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyP3B (58)
azd0120
Plasma Cell Myeloma
AstraZenecaP3B (58)
Bcma Car-T Cells
Plasma Cell Myeloma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (58)
Belantamab Mafodotin
Plasma Cell Myeloma
GlaxoSmithKlineP3B (58)
Bendamustine
Plasma Cell Myeloma
Uppsala UniversityP3B (58)
Dasatinib
Plasma Cell Myeloma
Centro de Atencion e Investigacion MedicaP4B (58)
gr1803
Plasma Cell Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd.P3B (58)
Jnj-79635322
Plasma Cell Myeloma
Janssen Research & Development, LLCP3B (58)
Ketorolac
Plasma Cell Myeloma
SanofiP3B (58)
Loratadine
Plasma Cell Myeloma
Emory UniversityP4B (58)
Panobinostat
Plasma Cell Myeloma
Abdullah KhanP3B (58)
Pegfilgrastim
Plasma Cell Myeloma
The Affiliated People's Hospital of Ningbo UniversityP3B (58)
Pembrolizumab
Plasma Cell Myeloma
Andrew Hantel, MDP3B (58)
ql2109
Plasma Cell Myeloma
Qilu Pharmaceutical Co., Ltd.P3B (58)
Ruxolitinib
Plasma Cell Myeloma
OncotherapeuticsP2B (58)
Zanubrutinib
Plasma Cell Myeloma
Anne Louise Tølbøll SørensenP4B (58)
Amoxicillin
Plasma Cell Myeloma
Monash UniversityP2/3B (57)
Clavulanic Acid
Plasma Cell Myeloma
Monash UniversityP2/3B (57)
Sctc21C
Plasma Cell Myeloma
Sinocelltech Ltd.P3B (57)
Showing 51 to 100 of 475 assets
PreviousPage 2 of 10Next